

AB0360 EFFICACY AND SAFETY OF THE PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST CR6086 ADDED TO METHOTREXATE IN DMARD-NAÏVE EARLY RA PATIENTS: A PHASE 2 RANDOMIZED CONTROLLED TRIAL
Published:
September 26, 2023
Publication:
Annals of the Rheumatic Diseases
Authors:
N. Tzaribachev ,Olga Kubassova Image Analysis Group, London, United Kingdom Mark Hinton Image Analysis Mikael Boesen University of Copen